NCT01825928View on ClinicalTrials.gov

An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

July 31, 2014

Conditions
Methamphetamine Dependence
Interventions
DRUG

Paliperidone

Paliperidone group,3mg/pill,3mg/day forced titration method,last 84 days

DRUG

placebo

placebo group,3mg/pill,3mg/day forced titration method,last 84 days

Trial Locations (1)

410011

The Second Xiangya Hospital of Central University, Changsha

All Listed Sponsors
lead

Wei Hao

OTHER

NCT01825928 - An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence | Biotech Hunter | Biotech Hunter